Broker│ Rating│ Target Price (HKD)JPMorgan│Overweight│40Morgan Stanley│Overweight│37.9CLSA│Outperform│33 –> 37Citi│Buy│36Goldman Sachs│Neutral│28.5Broker | OpinionJPMorgan | Strong growth in 1Q new business value offset the negative impact from lower profit, making the Company its sector top pickMorgan Stanley | 1Q new business value surged 76%, outpacing peers; business quality continued to improveCLSA | target price for CHINA LIFE (02628.HK) -0.620 (-2.027%) Short selling $352.42M; Ratio 22.781% 's H-shares was lifted as 1Q new business value growth significantly beat expectations and far outpaced peersCiti│ 1Q results mixed, with outstanding new business value growth, although embedded value growth was slightly lower than that of PING AN (02318.HK) -0.900 (-1.385%) Short selling $455.02M; Ratio 19.738% Goldman Sachs│1Q net profit growth beat expectations; new business value growth was robust(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)Related News Daiwa: 2026 Mainland Corporate Earnings Recovery May Accelerate but Not Broad-Based
AASTOCKS Financial News